Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

PRQR

ProQR Therapeutics N.V

Apr 28 • 04:00PM ET

1.48

-0.01 -0.67 %

Healthcare • Biotechnology • Netherlands • Micro • NASD

Peers: ALNY SRPT BMRN IONS ARWR QURE BBIO RGNX BLUE ADVM

| Held by: QQQS

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.45	Insider Own	32.21%	Shs Outstand	103.01M	Perf Week	-14.70%
Market Cap	155.94M	Forward P/E	-	EPS next Y	-0.70	Insider Trans	0.00%	Shs Float	71.43M	Perf Month	8.03%
Enterprise Value	63.84M	PEG	-	EPS next Q	-0.14	Inst Own	36.24%	Short Float	1.77%	Perf Quarter	-11.90%
Income	-47.66M	P/S	8.71	EPS this Y	-26.16%	Inst Trans	-0.42%	Short Ratio	2.53	Perf Half Y	-49.14%
Sales	17.91M	P/B	2.63	EPS next Y	-18.85%	ROA	-31.11%	Short Interest	1.26M	Perf YTD	-26.73%
Book/sh	0.56	P/C	1.44	EPS next 5Y	11.15%	ROE	-63.67%	52W High	3.10 -52.26%	Perf Year	-3.90%
Cash/sh	1.03	P/FCF	-	EPS past 3/5Y	21.80% 15.68%	ROIC	-68.87%	52W Low	1.33 11.28%	Perf 3Y	-32.11%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	68.13% -	Gross Margin	82.95%	Volatility	9.37% 10.03%	Perf 5Y	-76.87%
Dividend TTM	-	EV/Sales	3.56	EPS Y/Y TTM	-30.17%	Oper. Margin	-276.57%	ATR (14)	0.15	Perf 10Y	-74.48%
Dividend Ex-Date	-	Quick Ratio	3.09	Sales Y/Y TTM	-12.37%	Profit Margin	-266.13%	RSI (14)	38.49	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	3.09	EPS Q/Q	1.95%	SMA20	-16.40%	Beta	0.04	Target Price	9.02
Payout	-	Debt/Eq	0.28	Sales Q/Q	18.77%	SMA50	-11.48%	Rel Volume	3.45	Prev Close	1.49
Employees	-	LT Debt/Eq	0.19	Earnings	Mar 12 BMO	SMA200	-27.01%	Avg Volume	497.65K	Price	1.48
IPO	Sep 18, 2014	Option/Short	Yes / Yes	EPS/Sales Surpr.	-0.48% -16.25%	Trades		Volume	1,717,175	Change	-0.67%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)